A multicenter study assessing the value of (semi-)quantitative amyloid PET imaging for predicting progression within an Alzheimer's disease risk probability spectrum
Latest Information Update: 13 Sep 2022
At a glance
- Drugs Flutemetamol-F-18 (Primary)
- Indications Alzheimer's disease
- Focus Diagnostic use
Most Recent Events
- 13 Sep 2022 New trial record
- 04 Aug 2022 Results presented at the Alzheimer's Association International Conference 2022